Specifications
Pharmacopoeia | IP/IH |
ATC | L01XE07 |
PubChem | 208908 |
Formula | C29-H26-Cl-F-N4-O4-S.2C7-H8-O3-S.H2-O |
Molecular Mass | 915.433 |
Form | Powder |
Lapatinib is used to treat a certain type of breast cancer (HER2-positive). It works by slowing or stopping the growth of cancer cells.